Skip to main content
Equibles

Henshaw Capital LLC

Position in LLY — ELI LILLY & Co

CIK 2131483 WOBURN, MA
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$140,544,421
+$32,217,590 QoQ
Shares Held
117,176
-0.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
4.93%
of 13F equity value
Holder Rank
#323
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Henshaw Capital LLC holds $143,586,258 across 3 Drug Manufacturers - General names. LLY ranks #1 (97.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		117,176 $140,544,421
2 NVS
Novartis AG
 12,295 $1,926,872
3 AZN
Astrazeneca PLC
 5,880 $1,114,965

All Filings in LLY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $140,544,421 117,176
2026-03-31 $108,326,831 117,776
2025-12-31 $126,571,523 117,776
2025-09-30 $89,863,088 117,776
2025-06-30 $91,809,925 117,776
2025-03-31 $97,272,376 117,776
2024-12-31 $90,923,072 117,776
2024-09-30 $104,342,469 117,776
2024-06-30 $106,632,034 117,776
2024-03-31 $91,625,016 117,776
2023-12-31 $76,348,529 130,976
2023-09-30 $70,351,138 130,976
2023-06-30 $61,425,124 130,976
2023-03-31 $44,979,777 130,976
2022-12-31 $47,916,259 130,976
2022-09-30 $42,351,089 130,976
2022-06-30 $42,466,348 130,976
2022-03-31 $37,507,597 130,976
2021-12-31 $36,178,190 130,976
2021-09-30 $30,262,004 130,976
2021-06-30 $30,061,611 130,976
2021-03-31 $24,468,936 130,976
2020-12-31 $22,113,987 130,976
2020-09-30 $19,350,062 130,726
2020-06-30 $21,462,594 130,726
2020-03-31 $18,134,310 130,726

Report a Problem

Category
Description
Email (optional, for follow-up)